ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1832

Discovery of MicroRNAs in the Regulation of Inflammation and Bone Erosion in Rheumatoid Arthritis

Ellen M. Gravallese1, Yukiko Maeda1, Nicholas Farina2, Paul Fanning3 and Jane Lian2, 1Department of Medicine, Division of Rheumatology, University of Massachusetts Medical School, Worcester, MA, 2Department of Biochemistry, University of Vermont College of Medicine, Burlington, VT, 3Department of Orthopedics, University of Massachusetts Medical School, worcester, MA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Animal models, MicroRNA and rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint (Bone and Arthritis)

Session Type: Abstract Submissions (ACR)

Background/Purpose: Focal articular bone erosion in rheumatoid arthritis (RA) is mediated by osteoclasts and repair of erosion by osteoblasts is uncommon, despite the use of potent anti-inflammatory therapies. TNF treatment of primary calvarial osteoblasts from Wnt reporter (Top-gal) mice suppresses Wnt signaling activity in these cells, altering a pathway critical for osteoblast differentiation and function. Additional mechanisms inhibiting bone formation likely contribute to the persistence of articular erosion in this disease. We have shown in an animal model of RA that in the setting of resolving inflammation, repair of articular bone erosion can occur, accompanied by alterations in expression of components of the Wnt signaling pathway. MicroRNAs (miRNAs) are important regulators of skeletal remodeling and several miRNAs, including miR-23b and miR-155, have been shown to play a role in RA pathogenesis. Since miRNAs can regulate both inflammation and bone remodeling, we hypothesized that they might play a regulatory role in bone erosion in RA.

Methods: To address the potential role of miRNAs in these pathogenic events, we used a modification of the serum transfer model of RA for the study of bone erosion development and repair in which inflammation is induced, then allowed to resolve. We performed Fluidigm high-throughput expression profiling of 750 miRNAs in pooled synovial samples from non-arthritic and arthritic mice (peak inflammation, day 10), as well as mice with resolving inflammation (day 21). We also performed gene array (Affymetrix) analysis in these same RNA samples. We analyzed and compared gene and miRNA array expression, and performed gene ontology analyses to identify important pathways.

Results: We performed a principle component analysis that revealed three distinct sets of miRNAs with expression patterns that were significantly different between synovium from non-arthritic mice and mice with peak inflammation and resolving inflammation. We then compared miRNA and gene expression patterns and found 796 up-regulated genes in arthritic compared with non-arthritic synovium that are predicted targets of down-regulated miRNAs (1.5 fold or >). Relevant pathways from gene ontology analysis included extracellular matrix organization, cell cycle, inflammation, and blood vessel and bone development. We also found 639 genes to be down-regulated that are predicted targets of up-regulated miRNAs (1.5 fold or >) in arthritic compared with non-arthritic synovium. Gene ontology analysis included genes in the TGFß signaling pathway and genes regulating skeletal development. Finally, expression of several miRNAs was significantly altered during the resolution phase compared with peak inflammation, and some of these miRNAs may also regulate skeletal pathways.

Conclusion: In this murine model of bone erosion development and repair, we have identified miRNAs and associated genes whose relative expression is altered according to stage of inflammation/erosion. Further study of these miRNAs and regulated pathways may prove fruitful for elucidating mechanism and developing therapeutic strategies for bone remodeling.


Disclosure:

E. M. Gravallese,
None;

Y. Maeda,
None;

N. Farina,
None;

P. Fanning,
None;

J. Lian,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/discovery-of-micrornas-in-the-regulation-of-inflammation-and-bone-erosion-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology